Nemours Children’s Health System Expands Partnership with Bainbridge Health to Support Its Continued Commitment to Medication Safety
June 20, 2019 | Cision PRWeb
We are incredibly excited to be expanding our partnership with Nemours. Having worked with Nemours for more than 3 years, we have been privileged to have had the opportunity to work with and learn from one of the leading pediatric providers in the United States.
PHILADELPHIA (PRWEB) JUNE 20, 2019
Bainbridge Health, a spin-off company of the Children’s Hospital of Philadelphia, is excited to announce its implementation of their infusion pump safety solution at Nemours Children’s Hospital in Orlando, FL. Through the agreement, Bainbridge Health will support Nemours Children’s Hospital in their effort to improve safety, reduce cost and streamline clinician efficiency.
Nemours began more than 80 years ago, with a mission to restore and improve the health of children through quality care. Today, the system directly cares for 410,000 children annually from the Delaware Valley to Florida, including families who travel across the country and world for quality healthcare. Nemours promises to care for every child as their own. The systems’ hospitals are continually recognized among the top 5 percent of children’s health systems in the country.
“We are incredibly excited to be expanding our partnership with Nemours. Having worked with Nemours for more than 3 years, we have been privileged to have had the opportunity to work with and learn from one of the leading pediatric providers in the United States,” said Joseph Kaupp, CEO of Bainbridge Health. “As medication use data becomes more centralized, we can begin to more effectively share best-practices and learn important lessons from one another.”
According to the Food & Drug Administration, more than 2 million people are harmed by medication errors annually in the U.S. alone. Inpatient medication errors are a significant driver of patient harm, and infusion pumps remain the technology most associated with errors. Such errors have been shown to double the length of hospital stays on average, and the cost per incident is now estimated to exceed $7,000. The World Health Organization (WHO) recently added medication errors to its “hit list” and estimates the cost of medication errors to be $42 billion globally.
About Bainbridge Health
Bainbridge Health is a healthcare technology company founded within The Children’s Hospital of Philadelphia and in collaboration with leading adult and pediatric hospitals across the nation. Through its Med O.S.® Platform, Bainbridge Health provides healthcare organizations with clinical intelligence and support services to help clinicians and pharmacy leaders focus their time on decision-making—not “data clerking”. With the Med O.S.® Platform, clinicians can unlock the full value of their medication data in order to prevent errors, reduce costs and maintain compliance. For more information, please visit https://www.bainbridgehealth.com.
- Bainbridge Health Is Harnessing Medication Utilization Data to Conserve Waste and Manage The Supply of Critical Care Drugs Used to Treat COVID-19 Patients July 8, 2020
- The Impact of COVID-19 on Critical Care Medications June 10, 2020
- Clinical Data Trends Identified Across a Network of 11 Pediatric Hospitals April 28, 2020
- Do You Know What Doses Are Being Programmed in the OR? Make it an Expectation to Use Smart Infusion Pumps with DERS March 12, 2020
- Hard Stops: Everyone’s Using Them, Right? February 28, 2020